Similar Items: Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Review
- Oncolytic virus and PD-1/PD-L1 blockade combination therapy
- Real‐World Survival Over 25 Years in Extensive‐Stage Small‐Cell Lung Cancer: The Impact of Immune Checkpoint Inhibitors
- Intelligent nano‐platforms in breast cancer therapy: Current advances and future perspectives
- Efficacy and Safety of Regorafenib with or without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Systematic Review and Arm-Level Synthesis of Real-World Comparative Cohorts
- Molecular and genomic advances in breast cancer: A comprehensive review of predictive and therapeutic innovations
- Hematologic Glyco-Signatures: Emerging Blood-Based Sugar Codes Linked to Hyper-Aggressive Breast Cancer